<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Huo S</submitter><funding>Guangdong Provincial Science and Technology Project</funding><funding>the Specific Fund of State Key Laboratory of Dampness Syndrome of Chinese Medicine</funding><funding>National Natural Science Foundation of China</funding><funding>the Joint Innovation Project of  National Center for Protein Sciences (Beijing) and Guangdong Provincial Hospital of Chinese Medicine</funding><funding>the Specific Research Fund for TCM Science and Technology of Guangdong Provincial Hospital of Chinese Medicine</funding><funding>the  National Key Research and Development Program of China</funding><pagination>9500-9508</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8047722</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>6(14)</volume><pubmed_abstract>Hyperuricemia (HUA), a chronic disease caused by metabolic disorders of purine, is often accompanied by other diseases such as gout, type 2 diabetes mellitus (T2DM), and hyperlipidemia. However, little is known about the relationship between HUA and these diseases on the protein level. We performed label-free liquid chromatography MS/MS spectrometry analysis of urine samples from 26 HUA patients and 25 healthy controls, attempting to establish the possible protein links between HUA and these diseases by profiling urine proteome. A total of 2119 proteins were characterized in sample proteomes. Among them, 11 were found decreased and 2 were found increased in HUA samples. Plausible pathways found by enrichment analysis of these differentially expressed proteins (DEPs) include the processes f</pubmed_abstract><journal>ACS omega</journal><pubmed_title>Urinary Proteomic Characteristics of Hyperuricemia and Their Possible Links with the Occurrence of Its Concomitant Diseases.</pubmed_title><pmcid>PMC8047722</pmcid><funding_grant_id>81774216</funding_grant_id><funding_grant_id>SZ2020ZZ04</funding_grant_id><funding_grant_id>2017YFC0908403</funding_grant_id><funding_grant_id>YN2016XP01</funding_grant_id><funding_grant_id>31971360</funding_grant_id><funding_grant_id>2018B030322012</funding_grant_id><funding_grant_id>2017KT1821</funding_grant_id><funding_grant_id>SZ2020ZZ05</funding_grant_id><funding_grant_id>82074376</funding_grant_id><pubmed_authors>Yan M</pubmed_authors><pubmed_authors>Xu P</pubmed_authors><pubmed_authors>Li C</pubmed_authors><pubmed_authors>Xie Y</pubmed_authors><pubmed_authors>Wang H</pubmed_authors><pubmed_authors>Shao C</pubmed_authors><pubmed_authors>Bao K</pubmed_authors><pubmed_authors>Huo S</pubmed_authors><pubmed_authors>Song T</pubmed_authors><pubmed_authors>Tian R</pubmed_authors><pubmed_authors>Mao W</pubmed_authors><pubmed_authors>Chen X</pubmed_authors><pubmed_authors>Zhu W</pubmed_authors><pubmed_authors>Liu F</pubmed_authors></additional><is_claimable>false</is_claimable><name>Urinary Proteomic Characteristics of Hyperuricemia and Their Possible Links with the Occurrence of Its Concomitant Diseases.</name><description>Hyperuricemia (HUA), a chronic disease caused by metabolic disorders of purine, is often accompanied by other diseases such as gout, type 2 diabetes mellitus (T2DM), and hyperlipidemia. However, little is known about the relationship between HUA and these diseases on the protein level. We performed label-free liquid chromatography MS/MS spectrometry analysis of urine samples from 26 HUA patients and 25 healthy controls, attempting to establish the possible protein links between HUA and these diseases by profiling urine proteome. A total of 2119 proteins were characterized in sample proteomes. Among them, 11 were found decreased and 2 were found increased in HUA samples. Plausible pathways found by enrichment analysis of these differentially expressed proteins (DEPs) include the processes f</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Apr</publication><modification>2026-04-07T15:13:43.908Z</modification><creation>2022-02-09T16:06:05.327Z</creation></dates><accession>S-EPMC8047722</accession><cross_references><pubmed>33869930</pubmed><doi>10.1021/acsomega.0c06229</doi></cross_references></HashMap>